StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)

Close on Nov 17, 2026Market cap $1.97BP/E –Yield –

NeoGenomics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

NeoGenomics's enterprise value was $2.38B on Nov 11, 2026, against $1.40B a year earlier. Over the last 5 years it ranged from $275.05M to $4.19B, with a median of $1.47B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.38B+76.2%
2025Dec 31, 2025$1.35B-22.7%
2024Dec 31, 2024$1.75B-0.3%
2023Dec 29, 2023$1.75B+94.0%
2022Dec 30, 2022$903.31M-78.5%
2021Dec 31, 2021$4.19B-28.4%
2020Dec 31, 2020$5.86B+96.9%
2019Dec 31, 2019$2.98B+155.6%
2018Dec 31, 2018$1.16B+44.7%
2017Dec 29, 2017$804.72M+15.5%
2016Dec 30, 2016$696.60M+57.3%
2015Dec 31, 2015$442.95M+100.5%
2014Dec 31, 2014$220.92M+28.2%
2013Dec 31, 2013$172.31M+56.3%
2012Dec 31, 2012$110.23M+91.0%
2011Dec 30, 2011$57.70M–

More NeoGenomics figures

See a number that looks wrong?